Paloma Partners Management Co - PROTEOSTASIS THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2019$150,000
+9.5%
153,900
+427.1%
0.00%
+50.0%
Q2 2017$137,000–29,200–0.00%–
 Download
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q2 2019.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders